News
VantAI will use its machine learning capabilities to identify novel target-effector pairs that Halda can use in designing its ...
The company plans to launch the first version of its AI Advocate tool, aimed at helping patients manage and guide their ...
Hosted on MSN16d
The “Blueprint” That Wasn’t: Jeffries Misses Deadline For ...
House Democratic Leader Hakeem Jeffries's promise to unveil a "blueprint for a better America" has fallen short, as the self-imposed August 8 deadline passed without a detailed policy plan.
Hosted on MSN17d
Sanofi (NASDAQ:SNY) Q2 2025 Earnings Call Transcript
Sanofi (NASDAQ:SNY) Q2 2025 Earnings Call Transcript July 31, 2025 Thomas Kudsk Larsen: Hello, everyone. This is Thomas Kudsk Larsen from the Sanofi IR team. Welcome to the Q2 2025 conference call ...
Share - Sanofi to pay $130 million upfront and up to $265 million in potential regulatory milestones to Visirna Therapeutics, a majority-owned subsidiary of Arrowhead, which was previously granted ...
Nature's hardest teeth: Chitons offer blueprint for advanced dental and industrial materials by University of California, Irvine edited by Stephanie Baum, reviewed by Andrew Zinin Editors' notes ...
In a discovery that could broaden access to next-generation biologic medicines and vaccines, researchers at the University of Chicago Pritzker School of Molecular Engineering (UChicago PME) have ...
Drugmakers Sanofi, Eli Lilly, Novo Nordisk and AstraZeneca must face a lawsuit from two health centers accusing them of conspiring to restrict drug discounts offered to community pharmacies that ...
Sanofi is an R&D driven, AI-powered biopharma company committed to improving people’s lives and delivering compelling growth. We apply our deep understanding of the immune system to invent medicines ...
President Donald Trump said on Tuesday that the United States would initially place a "small tariff" on pharmaceutical imports before hiking it to 150% within 18 months and eventually to 250% in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results